Karyopharm Therapeutics | KPTI - Ebit

金融业

USD

USD 108.42M

现金及等价物

USD 60.54M

USD 1.48M

USD 103.15M

USD 92.06M

USD 299.23M

股息收益率

0

USD -17.84M

USD -26.2M

325

EPS每股收益

USD -2.22

股本和储备

USD -292.93M

USD 32.6M

债务利息支出

USD 12.62M

USD -0.15

USD 278.22M

USD 1.1B

USD -102.2M

USD 51.92M

USD -17.84M

普通股股本

USD 18.31M

USD -39.9M

USD 34.08M

销售和管理费用

USD 9.56M

USD 4.04M

贸易债权人

USD 4M

应收帐款人

USD 26.18M

	Ebit	更改		日
AbbVie	USD 4.73B		1.08B	2026-03
Abbott	USD 1.85B		684M	2026-03
Amgen	USD 3.83B		130M	2026-03
AstraZeneca	USD 7.11B		4.14B	2026-03
BioCryst Pharmaceuticals	USD 260.38M		230.79M	2025-12
Bristol-Myers Squibb	USD 3.56B		90M	2026-03
Eli Lilly	USD 9.78B		792M	2026-03
Enanta Pharmaceuticals	USD -23.54M		6.31M	2024-12
GlaxoSmithKline	GBP 2.29B		856M	2026-03
Incyte	USD 344.17M		39.71M	2026-03
J&J	USD 6.62B		1.51B	2026-03
Karyopharm Therapeutics	USD -17.84M		8.44M	2025-12
MacroGenics	USD -31.88M		19.79M	2026-03
Merck	USD -1.88B		8.12B	2026-03
Nektar Therapeutics	USD -19.09M		15.26M	2025-12
Novartis	USD 4.18B		118M	2026-03
Novartis	USD 4.18B		118M	2026-03
Pfizer	USD 4.99B		340M	2026-03
Regeneron Pharmaceuticals	USD 744.8M		153.8M	2026-03
Roche Holding	CHF 9.56B		2.1B	2025-12
Takeda	JPY -13.62B		271.11B	2026-03
Tectonic Therapeutic	USD -27.3M		5.78M	2026-03
TG Therapeutics	USD 34.8M		15.7M	2026-03
Ultragenyx Pharmaceutical	USD -216M		102M	2026-03
Xencor	USD -77.86M		24.23M	2026-03